{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:10:59Z","timestamp":1787022659445,"version":"build-2736575974"},"reference-count":100,"publisher":"Informa UK Limited","issue":"5","license":[{"start":{"date-parts":[[2016,3,16]],"date-time":"2016-03-16T00:00:00Z","timestamp":1458086400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Discovery"],"published-print":{"date-parts":[[2016,5,3]]},"DOI":"10.1517\/17460441.2016.1160051","type":"journal-article","created":{"date-parts":[[2016,3,14]],"date-time":"2016-03-14T04:43:49Z","timestamp":1457930629000},"page":"515-523","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":72,"title":["The Preclinical and Clinical Effects of Vilazodone for the Treatment of Major Depressive Disorder"],"prefix":"10.1517","volume":"11","author":[{"given":"Zeyad T.","family":"Sahli","sequence":"first","affiliation":[{"name":",","place":["USA"]},{"name":",","place":["Lebanon"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradeep","family":"Banerjee","sequence":"additional","affiliation":[{"name":"Forest Research Institute, Jersey City, NJ, USA, an affiliate of Allergan Inc"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank I.","family":"Tarazi","sequence":"additional","affiliation":[{"name":",","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2016,3,16]]},"reference":[{"key":"e_1_3_4_3_1","unstructured":"World Health Organization. Depression Fact sheet No. 369 [updated 2012 October]. Available from: http:\/\/www.who.int\/mediacentre\/factsheets\/fs369\/en\/"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.62.6.617"},{"key":"e_1_3_4_5_1","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM 5. Arlington VA: American Psychiatric Association; 2013.","DOI":"10.1176\/appi.books.9780890425596"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.157.10.1552"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.2051-5545.2010.tb00298.x"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1520-6394(1998)7:1 <18::AID-DA5>3.0.CO;2-B"},{"key":"e_1_3_4_9_1","first-page":"S1","article-title":"Norepinephrine and selective norepinephrine reuptake inhibitors in depression and mood disorders: their pivotal roles","volume":"26","author":"Blier P","year":"2001","unstructured":"Blier P. Norepinephrine and selective norepinephrine reuptake inhibitors in depression and mood disorders: their pivotal roles. J Psychiatry Neurosci. 2001;26(Suppl):S1\u20132.","journal-title":"J Psychiatry Neurosci"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v63n0309"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.11096su1c.01"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.med.60.042307.110802"},{"key":"e_1_3_4_13_1","volume-title":"Stahl\u2019s essential psychopharmacology: neuroscientific basis and practical applications","author":"Stahl SM","year":"2013","unstructured":"Stahl SM. Stahl\u2019s essential psychopharmacology: neuroscientific basis and practical applications. New York (NY): Cambridge University Press; 2013."},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2012.0537"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/40.2.288"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-0327(82)90025-8"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1990.01810170011002"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1976.01770070041003"},{"key":"e_1_3_4_19_1","article-title":"Monamine dysfunction and the pathophysiology and treatment of depression","author":"Charney DS","year":"1998","unstructured":"Charney DS. Monamine dysfunction and the pathophysiology and treatment of depression. J Clin Psychiatry. 1998;59(Suppl 14):11\u201314.","journal-title":"J Clin Psychiatry"},{"key":"e_1_3_4_20_1","article-title":"History and evolution of the monoamine hypothesis of depression","author":"Hirschfeld R","year":"2000","unstructured":"Hirschfeld R. History and evolution of the monoamine hypothesis of depression. J Clin Psychiatry. 2000;61(Suppl 6):4\u20136.","journal-title":"J Clin Psychiatry"},{"issue":"6","key":"e_1_3_4_21_1","first-page":"39","article-title":"A new antidepressant","volume":"31","author":"Glazer WM","year":"2011","unstructured":"Glazer WM. A new antidepressant. Behav Healthc. 2011;31(6):39\u201340.","journal-title":"Behav Healthc"},{"key":"e_1_3_4_22_1","first-page":"933","volume-title":"Psychopharmacology: the fourth generation of progress","author":"Maes M","year":"1995","unstructured":"Maes M, Meltzer HY. The serotonin hypothesis of major depression. In: Bloom FE, Kupfer DJ, editors. Psychopharmacology: the fourth generation of progress. New York, NY: Raven Press; 1995. p. 933\u2013944."},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S20683"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/syn.890010103"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/syn.890010511"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(92)90914-U"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(92)90292-C"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00491480"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.1996.67052204.x"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0703297"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/syn.890150310"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-6147(94)90315-8"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(89)90803-0"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molbrainres.2004.06.028"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.24.14476"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.107.041186"},{"issue":"15","key":"e_1_3_4_37_1","first-page":"13","article-title":"Prevention of relapse and recurrence in depression: the role of long-term pharmacotherapy and psychotherapy","volume":"64","author":"Nierenberg AA","year":"2003","unstructured":"Nierenberg AA, Petersen TJ, Alpert JE. Prevention of relapse and recurrence in depression: the role of long-term pharmacotherapy and psychotherapy. J Clin Psychiatry. 2003;64(15):13\u201317.","journal-title":"J Clin Psychiatry"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543780903286396"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145713000679"},{"key":"e_1_3_4_40_1","first-page":"7","article-title":"Evolution of remission as the new standard in the treatment of depression","volume":"60","author":"Nierenberg A","year":"1998","unstructured":"Nierenberg A, Wright E. Evolution of remission as the new standard in the treatment of depression. J Clin Psychiatry. 1998;60:7\u201311.","journal-title":"J Clin Psychiatry"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.178.3.234"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200005183422001"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1P772"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199506000-00011"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4522(91)90128-B"},{"issue":"2","key":"e_1_3_4_46_1","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/S0022-3565(25)10650-2","article-title":"Effects of acute and repeated administration of antidepressant drugs on extracellular levels of 5-hydroxytryptamine measured in vivo","volume":"274","author":"Kreiss DS","year":"1995","unstructured":"Kreiss DS, Lucki I. Effects of acute and repeated administration of antidepressant drugs on extracellular levels of 5-hydroxytryptamine measured in vivo. J Pharmacol Exp Ther. 1995;274(2):866\u2013876.","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(95)02159-0"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/0893-133X(95)00240-E"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1177\/026988110001400208"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-2236(96)10037-0"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-199707003-00004"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)08007-5"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.2006.163.11.1905"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1021\/cn200084v"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002130051156"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2013.07.014"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(94)90071-X"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1995.tb14990.x"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.1995.64041585.x"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4522(97)00565-4"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2005.01.018"},{"key":"e_1_3_4_62_1","unstructured":"Kehne JH Bartoszyk GD Greiner HE editors. In vitro characterization of vilazodone as a dual-acting serotonin reuptake receptor and 5-HT1A receptor partial agonist. Poster presented at: 65th Annual Meeting of the Society of Biological Psychiatry Meeting; 2010."},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.102.034280"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2004.09.009"},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(01)00799-3"},{"issue":"3","key":"e_1_3_4_66_1","first-page":"193","article-title":"Drug evaluation: vilazodone\u2013a combined SSRI and 5-HT1A partial agonist for the treatment of depression","volume":"10","author":"de Paulis T","year":"2007","unstructured":"de Paulis T. Drug evaluation: vilazodone\u2013a combined SSRI and 5-HT1A partial agonist for the treatment of depression. IDrugs. 2007;10(3):193\u2013201.","journal-title":"IDrugs"},{"key":"e_1_3_4_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(96)00999-5"},{"key":"e_1_3_4_68_1","volume-title":"Acute vilazodone administration induces hypothermia in mice through a 5-HT1A mechanism. Neuropsychopharmacology","author":"Garcia-Garcia A","year":"2013","unstructured":"Garcia-Garcia A, Banerjee P, Leonardo ED, editors. Acute vilazodone administration induces hypothermia in mice through a 5-HT1A mechanism. Neuropsychopharmacology. 4 Crinan St, London N1 9xw, England: Nature Publishing Group Macmillan Building; 2013."},{"issue":"18","key":"e_1_3_4_69_1","first-page":"1551","article-title":"Vilazodone: A novel antidepressant","volume":"69","author":"Choi E","year":"2012","unstructured":"Choi E, Zmarlicka M, Ehret MJ. Vilazodone: A novel antidepressant. Am J Hosp Pharm. 2012;69(18):1551\u20131557.","journal-title":"Am J Hosp Pharm"},{"key":"e_1_3_4_70_1","doi-asserted-by":"publisher","DOI":"10.5414\/CP201826"},{"key":"e_1_3_4_71_1","unstructured":"Viibryd [prescribing information]. St. Louis MO: Forest Pharmaceuticals LLC; 2015."},{"key":"e_1_3_4_72_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199631030-00004"},{"key":"e_1_3_4_73_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-013-0061-5"},{"key":"e_1_3_4_74_1","doi-asserted-by":"publisher","DOI":"10.2165\/11207550-000000000-00000"},{"key":"e_1_3_4_75_1","doi-asserted-by":"publisher","DOI":"10.1358\/dot.2011.47.7.1622076"},{"key":"e_1_3_4_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2014.08.003"},{"key":"e_1_3_4_77_1","unstructured":"Brown PC. Center for drug evaluation and research: tertiary pharmacology\/toxicology review. Washington (DC): U.S. Food and Drug Administration; 2010. Reference ID 2891807 [Viibryd]."},{"key":"e_1_3_4_78_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.08m04637"},{"key":"e_1_3_4_79_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.10m06596"},{"key":"e_1_3_4_80_1","doi-asserted-by":"publisher","DOI":"10.2217\/17410541.6.2.217"},{"key":"e_1_3_4_81_1","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0000000000000057"},{"key":"e_1_3_4_82_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.14m08992"},{"key":"e_1_3_4_83_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e31822c6741"},{"key":"e_1_3_4_84_1","doi-asserted-by":"publisher","DOI":"10.1002\/da.22365"},{"key":"e_1_3_4_85_1","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0000000000000096"},{"key":"e_1_3_4_86_1","article-title":"Efficacy and safety of vilazodone in patients with generalized anxiety disorder: a randomized, double-blind, placebo-controlled, flexible-dose trial","author":"Durgam S","year":"2015","unstructured":"Durgam S, Gommoll C, Forero G, et al. Efficacy and safety of vilazodone in patients with generalized anxiety disorder: a randomized, double-blind, placebo-controlled, flexible-dose trial. J Clin Psychiatry. Forthcoming 2015.","journal-title":"J Clin Psychiatry"},{"key":"e_1_3_4_87_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2012.228"},{"issue":"18","key":"e_1_3_4_88_1","first-page":"1549","article-title":"Vilazodone\u2019s comparative merits yet to be demonstrated","volume":"69","author":"Dopheide JA","year":"2012","unstructured":"Dopheide JA. Vilazodone\u2019s comparative merits yet to be demonstrated. Am J Hosp Pharm. 2012;69(18):1549.","journal-title":"Am J Hosp Pharm"},{"key":"e_1_3_4_89_1","volume-title":"An evaluation of the effect of vilazodone on cardiac safety","author":"Morganroth J","year":"2010","unstructured":"Morganroth J, Thorn M, Gallipoli S, et al. editors. An evaluation of the effect of vilazodone on cardiac safety. Anaheim, CA: American Society of Health-System Pharmacy Midyear Clinical Meeting and Exihibition; 2010."},{"key":"e_1_3_4_90_1","doi-asserted-by":"publisher","DOI":"10.4103\/0250-474X.51941"},{"key":"e_1_3_4_91_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa052744"},{"key":"e_1_3_4_92_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2009.01377.x"},{"key":"e_1_3_4_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0327(99)00050-6"},{"key":"e_1_3_4_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.physbeh.2004.08.018"},{"key":"e_1_3_4_95_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijgo.2010.02.014"},{"key":"e_1_3_4_96_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2009.01309.x"},{"key":"e_1_3_4_97_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145709000406"},{"key":"e_1_3_4_98_1","doi-asserted-by":"crossref","DOI":"10.1007\/s00213-015-4198-1","article-title":"Differential effects of vilazodone versus citalopram and paroxetine on sexual dysfunction and serotonin transporter and receptors in male rats","author":"Oosting RS","year":"2016","unstructured":"Oosting RS, Chan JS, Olivier B, et al. Differential effects of vilazodone versus citalopram and paroxetine on sexual dysfunction and serotonin transporter and receptors in male rats. Psychopharmacol. 2016;233(6):1025\u20131034.","journal-title":"Psychopharmacol"},{"key":"e_1_3_4_99_1","doi-asserted-by":"publisher","DOI":"10.1111\/jsm.12004"},{"key":"e_1_3_4_100_1","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0000000000000075"},{"issue":"4","key":"e_1_3_4_101_1","first-page":"747","article-title":"Comparison of sexual functioning in clinical and nonclinical populations using the Changes in Sexual Functioning Questionnaire (CSFQ)","volume":"33","author":"Clayton AH","year":"1997","unstructured":"Clayton AH, McGarvey EL, Clavet GJ, et al. Comparison of sexual functioning in clinical and nonclinical populations using the Changes in Sexual Functioning Questionnaire (CSFQ). Psychopharmacol Bull. 1997;33(4):747\u2013753.","journal-title":"Psychopharmacol Bull"},{"key":"e_1_3_4_102_1","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0000000000000045"}],"container-title":["Expert Opinion on Drug Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/tandfonline.com\/doi\/pdf\/10.1517\/17460441.2016.1160051","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/17460441.2016.1160051","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T09:54:23Z","timestamp":1770890063000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1517\/17460441.2016.1160051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,16]]},"references-count":100,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5,3]]}},"alternative-id":["10.1517\/17460441.2016.1160051"],"URL":"https:\/\/doi.org\/10.1517\/17460441.2016.1160051","relation":{},"ISSN":["1746-0441","1746-045X"],"issn-type":[{"value":"1746-0441","type":"print"},{"value":"1746-045X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,16]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iedc20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iedc20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2015-10-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-02-26","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-03-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}